If you need more lookups,
subscriptions start at $34 USD/month.
Matt Beaudet Location
Portland, OR, US
Matt Beaudet Work
2024 -now President and CEO @
2026 -now Task Force Member @ Oregon Life Sciences Task Force
2023 -now Advisory Board Member @
2017 -now Board Member @
2023 -2026 Board Member @
2014 -2024 CEO and Co-founder @
2013 -2019 Founder and Member of the Board of Directors @ Fertilab Thinkubator
1997 -2012 15-Year Career Progression: R and D Scientist to Senior Program Manager @
Matt Beaudet Education
University of Oregon
B.S. (Molecular Biology)
1993-1997
Matt Beaudet Skills
Board Level
Board Administration
Board Operation
Product Development
Cell Biology
Cross-functional Team Leadership
Research
Instrumentation
Cell
Technology Transfer
R&D
Biotechnology
Life Sciences
Biochemistry
Technology Evaluation
Cell Based Assays
Technology Development
Data Analysis
Intellectual Property
Commercialization
Product Launch
Lifesciences
User Experience
Molecular Biology
Drug Discovery
Pharmaceutical Industry
Proteomics
Assay Development
Cell Culture
Immunoassays
High Throughput Screening
Sequencing
Biopharmaceuticals
DNA sequencing
Immunology
Protein Chemistry
DNA
PCR
qPCR
Bioinformatics
Genomics
Genetics
Drug Development
Cross Functional Team
Rapid Prototyping
Collaborative Innovation
Competitive Analysis
Customer Research
High Throughput
Cross Functional Team Leadership
Prototyping
Matt Beaudet Summary
Matt Beaudet, based in Portland, OR, US, is currently a President and CEO at Araceli Biosciences. Matt Beaudet brings experience from previous roles at Oregon Life Sciences Task Force, Portland State University, Starve Ups and Sedia Biosciences Corp.. Matt Beaudet holds a 1993 - 1997 B.S. in Molecular Biology @ University of Oregon. With a robust skill set that includes Board Level, Board Administration, Board Operation, Product Development, Cell Biology and more. Matt Beaudet has 3 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Matt Beaudet?
Find contact details for 700 million professionals.